HIV and depression: 2008 review and update

Area of Science:

• Medical Research
• Psychiatry
• Epidemiology

Background:

• Clinicians have long been concerned about depression in patients with Acquired Immunodeficiency Syndrome (AIDS).
• Numerous specialists have investigated the prevalence, causes, and effects of depressive disorders and symptoms in the context of HIV.
• This review synthesizes existing research on depression within the HIV community.

Purpose of the Study:

• To review methodologic challenges in assessing depression prevalence.
• To summarize findings on depression rates, correlates, and consequences in the HIV-positive population.
• To examine the impact of depression on HIV illness progression and patient behaviors.

Main Methods:

• Literature review of studies on depression and HIV/AIDS.
• Analysis of epidemiological, clinical, and behavioral research.
• Synthesis of findings from international studies, including those in developing countries.

Main Results:

• Methodologic difficulties exist in accurately determining depression prevalence.
• Depression is prevalent across various segments of the HIV community.
• Depression negatively affects HIV illness progression, medication adherence, employment, and risk behaviors.

Conclusions:

• Depression is a significant comorbidity in HIV/AIDS, with substantial impacts on health outcomes.
• Effective psychopharmacologic and psychotherapeutic treatments are essential.
• Cross-national research highlights challenges in diagnostic definitions and measurement for global mental health initiatives.